We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 24, 2021

Associations of Empagliflozin With LV Volumes, Mass, and Function in Patients With HFrEF

JAMA Cardiology


Additional Info

JAMA Cardiology
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial
JAMA Cardiol 2021 Jan 06;[EPub Ahead of Print], M Omar, J Jensen, M Ali, PH Frederiksen, C Kistorp, L Videbæk, MK Poulsen, CD Tuxen, S Möller, F Gustafsson, L Køber, M Schou, JE Møller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading